Health Condition 1: M678- Other specified disorders of synovium and tendon
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with chronic shoulder pain of more than 3 months of duration, with Rotator cuff pathology as confirmed by definitive clinical diagnosis ( history and physical examination, including special test- Neer, Hawkins-Kennedy and drop arm test.) 2. Magnetic resonance imaging (MRI) confirming the evidence of RC pathology (partial thickness tear, tendinosis and/or bursitis ) and having strong correlation with physical examination findings. 3. Age range between 18 and 70 years.
Exclusion criteria
Exclusion criteria: 1. Previous shoulder surgery. 2. Full thickness rotator cuff lesions on MRI scan. 3. Shoulder fracture within past 6 months. 4. Patient having calcific tendinitis, adhesive capsulitis or glenohumeral osteoarthritis. 5. Patient with inflammatory and systemic rheumatic disorders. 6. Pregnant and lactating women. 7. Severe bleeding diathesis or on anticoagulation therapy. 8. Patient with severe systemic illness ( heart, lung, hepatic, renal , psychiatric , connective tissue disorder, neurological, uncontrolled diabetes mellitus or hypertension.) 9. Presence of systemic infection or local infection at the injection site. 10. Significant allergic reaction or hypersensitivity to corticosteroid, local anaesthetic, or dextrose. 11. Patient diagnosed with malignancy. 12. Unwillingness to abstain from NSAIDS for at least 3 days post-intervention 13. Patient taken any mode of corticosteroid therapy (systemic, injection) in past 2 months. 14. Presence of joint prosthesis or joint instability.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shoulder Pain and Disability Index (SPADI) scoreTimepoint: Baseline Shoulder Pain and Disability Index (SPADI) score and 1, 2, and 3 months after third prolotherapy session | — |
Secondary
| Measure | Time frame |
|---|---|
| Active range of motion ( abduction, forward flexion, internal rotation, external rotation of shoulder measured by goniometer( angle at onset of pain will be measured three times to obtain median value)Timepoint: Baseline Active range of motion and at 1, 2, and 3 months after third prolotherapy session;Overall shoulder satisfaction measured by Likert scaleTimepoint: At 1, 2, and 3 months after third prolotherapy session;Average shoulder pain at movement in preceding 1 week measured by visual analogue scale ( VAS- week)Timepoint: Baseline VAS- week and at 1, 2, and 3 months after third prolotherapy session;Muscle strength testing measured by medical research council scale (MRC)Timepoint: Baseline muscle strength and at 3 months after third prolotherapy session;Any adverse eventsTimepoint: Recorded peri ntervention and post intervention | — |
Countries
India
Contacts
Government Medical College and Hospital, Chandigarh